222 related articles for article (PubMed ID: 15375507)
1. Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.
Terashita Y; Ishiguro H; Haruki N; Sugiura H; Tanaka T; Kimura M; Shinoda N; Kuwabara Y; Fujii Y
Oncol Rep; 2004 Oct; 12(4):827-31. PubMed ID: 15375507
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic roles of PABPC1 in esophageal cancer: correlation with tumor progression and postoperative survival.
Takashima N; Ishiguro H; Kuwabara Y; Kimura M; Haruki N; Ando T; Kurehara H; Sugito N; Mori R; Fujii Y
Oncol Rep; 2006 Mar; 15(3):667-71. PubMed ID: 16465428
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
[TBL] [Abstract][Full Text] [Related]
4. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
5. A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients.
Kurehara H; Ishiguro H; Kimura M; Mitsui A; Ando T; Sugito N; Mori R; Takashima N; Ogawa R; Fujii Y; Kuwabara Y
Int J Oncol; 2007 Feb; 30(2):421-8. PubMed ID: 17203224
[TBL] [Abstract][Full Text] [Related]
6. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
7. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
[TBL] [Abstract][Full Text] [Related]
8. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
Faried A; Faried LS; Usman N; Kato H; Kuwano H
Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
[TBL] [Abstract][Full Text] [Related]
9. High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.
Warnecke-Eberz U; Metzger R; Miyazono F; Baldus SE; Neiss S; Brabender J; Schaefer H; Doerfler W; Bollschweiler E; Dienes HP; Mueller RP; Danenberg PV; Hoelscher AH; Schneider PM
Clin Cancer Res; 2004 Jun; 10(11):3794-9. PubMed ID: 15173087
[TBL] [Abstract][Full Text] [Related]
10. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
11. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
12. Low expression of claudin-4 is associated with poor prognosis in esophageal squamous cell carcinoma.
Sung CO; Han SY; Kim SH
Ann Surg Oncol; 2011 Jan; 18(1):273-81. PubMed ID: 20839069
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of detecting mucin 1 mRNA in diagnosing occult lymph node micrometastasis in esophageal cancer patients.
Liu XY; Chen G; Wang Z; Liu FY
Ai Zheng; 2007 Feb; 26(2):194-9. PubMed ID: 17298752
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of MCM4 in esophageal cancer].
Huang XP; Zhang X; Su XD; Ma GW; Zhao JM; Rong TH
Ai Zheng; 2007 Jan; 26(1):96-9. PubMed ID: 17222376
[TBL] [Abstract][Full Text] [Related]
16. Expression of hypoxia-inducible factor-1alpha in esophageal squamous cell carcinoma.
Matsuyama T; Nakanishi K; Hayashi T; Yoshizumi Y; Aiko S; Sugiura Y; Tanimoto T; Uenoyama M; Ozeki Y; Maehara T
Cancer Sci; 2005 Mar; 96(3):176-82. PubMed ID: 15771621
[TBL] [Abstract][Full Text] [Related]
17. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
Schneider S; Uchida K; Brabender J; Baldus SE; Yochim J; Danenberg KD; Salonga D; Chen P; Tsao-Wei D; Groshen S; Hoelscher AH; Schneider PM; Danenberg PV
J Am Coll Surg; 2005 Mar; 200(3):336-44. PubMed ID: 15737843
[TBL] [Abstract][Full Text] [Related]
19. MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma.
Verma A; Shukla NK; Deo SV; Gupta SD; Ralhan R
Oncology; 2005; 68(4-6):462-70. PubMed ID: 16024937
[TBL] [Abstract][Full Text] [Related]
20. STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma.
Kita Y; Mimori K; Iwatsuki M; Yokobori T; Ieta K; Tanaka F; Ishii H; Okumura H; Natsugoe S; Mori M
Ann Surg Oncol; 2011 Jan; 18(1):261-72. PubMed ID: 20734150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
